ARTICLE | Company News
InSite, QLT deal
June 15, 2015 7:00 AM UTC
QLT will acquire InSite in a stock deal. Last week, InSite submitted an NDA to FDA for BromSite to reduce postoperative inflammation and prevent pain after cataract surgery. BromSite is low-dose brom...